By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: The Absolute Case for Relative Value Units
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Business > Finance > The Absolute Case for Relative Value Units
BusinessFinance

The Absolute Case for Relative Value Units

DavidEWilliams
DavidEWilliams
Share
3 Min Read
SHARE

medium_9419861538

medium_9419861538

Fee-for-service methodologies, especially relative-value units (RVUs), keep creeping back into alternative payment models like capitation.  Maybe we should take the hint and adapt RVUs to the new environment rather than throwing them out the window. That’s the essential message of a persuasive Perspective by Erick Stecker and Steven Schroeder in the latest New England Journal of Medicine.

Capitation works well at the level of an overall health system, but it’s trickier to apply at the level of small physician groups due to challenges in risk adjustment in small populations and concerns about conflicts of interest. That means physicians usually get paid on some kind of RVU basis. Typical RVU methodologies only account for physician time, skill and intensity. But RVUs could be improved by using comparative effectiveness research to give more weight to activities that are likely to improve patient outcomes. The authors provide an example of stenting for chronic stable angina, which currently has a Medicare RVU weighting of 11.2. They propose boosting it by 25% for those with “AUC score of 7,8, or 9 and conducted in cath labs with an approved AUC auditing process” while lowering the RVU by 50 to 75 percent for those for whom stenting is less likely to be helpful.

More Read

June 23-24 OneMedForum New York
More Medical Monopoly: How Steve Brill Got It Wrong
Rebuttal to Last Week’s Blog, Death of Disease Management (Finally)
Good News and Bad News for Young Medical Professionals
Hospitals May Not Be Ready for ICD-10

RVU-based systems are well entrenched because they are already understood and used by financial managers, are included in software used by health systems, and are understood by physicians. When RVUs are distorted they lead to rapid and profound changes in physician behavior. The authors cite the growth of doctor-owned specialty surgical centers and imaging centers as examples. Why not use value-based RVUs to achieve rapid increases in behaviors that are desirable from a value perspective?

RVUs are tweaked frequently so there’s no need for a high risk, big bang approach. RVUs can be changed as better evidence becomes available and to adjust to changes in physician behavior.

It sounds like a good plan to me.

photo credit: Nicholas Eckhart via photopin cc

TAGGED:relative value unitsRVU
Share This Article
Facebook Copy Link Print
Share

Stay Connected

1.5KFollowersLike
4.5KFollowersFollow
2.8KFollowersPin
136KSubscribersSubscribe

Latest News

How Virtual Schools Deliver Therapy and Special-Education Support for Children With Disabilities -- AI-generated illustration
How Virtual Schools Deliver Therapy and Special-Education Support for Children With Disabilities
Health News Therapy
July 31, 2026
mri technology
Why Preventive MRI Maintenance Is Essential for Hospitals
Business Hospital Administration
July 24, 2026
senior on computer
Health and Digital Safety Risks Older Adults Should Know
Senior Care
July 24, 2026
The Riskiest Part of Getting Sick Isn't the Diagnosis. It's the Handoff
The Riskiest Part of Getting Sick Isn’t the Diagnosis. It’s the Handoff
Health
July 20, 2026

You Might also Like

Report: Branded Drug Use Sharply Down, Generics Way Up

April 21, 2011

Who Leads Whom?

October 12, 2015
pfizer and clinical data transparency
BusinessMedical RecordsPolicy & Law

Pfizer to Expand Clinical Trial Data Access, Takes Step Toward Transparency

December 6, 2013

Bacteria and Mobile Devices

June 26, 2011
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2026 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?